[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”26-07-2011″ enddate=”26-01-2012″ width=”300″ height=”245″] Thousand Oaks-based Amgen is buying a leukemia drug maker for $1.2 billion in a bid to boost its blockbuster drug lineup. Amgen, the world’s largest biotech company, said Jan. 26 that it will purchase Maryland-based Micromet, maker of an experimental leukemia drug. Investors of Microment will Read More →
PBS Biotech, a Camarillo-based startup focused on biotechnology equipment founded by a former Amgen scientist, has added major firepower to its advisory board with a key former Amgen executive. George Morrow oversaw global operations for Thousand Oaks-based Amgen, the world’s largest biotech firm, for eight years before retiring last year. He came to Amgen after Read More →
Kevin Sharer, chairman and CEO of Amgen, is set to retire in May, the Thousand Oaks-based company said on Dec. 15. Current president and chief operating officer Robert Bradway will become the company’s new CEO. Sharer led Amgen, the largest private-sector employer in Ventura County, for 11 years. He oversaw the company’s transition from the Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”19-04-2011″ enddate=”19-10-2011″ width=”300″ height=”245″] Thousand Oaks-based Amgen is laying off 226 people at its headquarters as part of a restructuring of its research operations. Worldwide, the R&D shakeup will affect 380 staff members, but the company’s headquarters are bearing the brunt of the cuts. The company said the layoffs are Read More →